Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate

被引：74
|
作者：
Arora, B [1 ]
Kumar, L [1 ]
Sharma, A [1 ]
Wadhwa, J [1 ]
Kochupillai, V [1 ]
机构：
[1] All India Inst Med Sci, RDHMM, New Delhi 110049, India
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷 / 02期
关键词：
D O I：
10.1093/annonc/mdh068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [1] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [2] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
  • [3] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    Hasford, J
    Pfirrmann, M
    Hochhaus, A
    LEUKEMIA, 2005, 19 (04) : 497 - 499
  • [4] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    J Hasford
    M Pfirrmann
    A Hochhaus
    Leukemia, 2005, 19 : 497 - 499
  • [5] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    BLOOD, 2006, 107 (02) : 480 - 482
  • [6] PROANGIOGENIC CYTOKINES IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB MESYLATE
    Kotlyarchuk, K.
    Lukavetsky, L.
    Danysh, O.
    Lukjanova, A.
    Kolisnyk, M.
    Maslyak, Z.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 349 - 349
  • [7] Changes of Immunological, Cytogenetic and Haematological Profiles in Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Gaiz, Almottesembellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S286 - S286
  • [8] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [9] Renal phosphate loss in Iraqi chronic myeloid leukemia patients treated by imatinib mesylate
    Al-Taee, Huda A.
    Athab, Azhar K.
    Ali, Ala
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 72 - 76
  • [10] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
    C Schoch
    T Haferlach
    W Kern
    S Schnittger
    U Berger
    R Hehlmann
    W Hiddemann
    A Hochhaus
    Leukemia, 2003, 17 : 461 - 463
12345